(Q34321295)

1 August 2017

Clinical features of acute anaphylaxis in patients admitted to a university hospital: an 11-year retrospective review (1985-1996). (English)

1 reference

1 August 2017

1 reference

1 reference

Cianferoni A

1

1 reference

1 August 2017

Novembre E

2

1 reference

1 August 2017

Mugnaini L

3

1 reference

1 August 2017

Lombardi E

4

1 reference

1 August 2017

Bernardini R

5

1 reference

1 August 2017

Pucci N

6

1 reference

1 August 2017

Vierucci A

7

1 reference

1 August 2017

1 July 2001

1 reference

Annals of Allergy, Asthma & Immunology

1 August 2017

1 reference

1 August 2017

87

1 reference

1 August 2017

1

1 reference

1 August 2017

27-32

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

1 August 2017

1 reference

7 January 2021

Idiopathic anaphylaxis: a series of 335 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Biphasic systemic anaphylaxis: an inpatient and outpatient study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Biphasic and protracted anaphylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Drug-associated anaphylaxis: 20 years of reporting in The Netherlands (1974-1994) and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Anaphylaxis in children: clinical and allergologic features

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Assessment of patients who have experienced anaphylaxis: a 3-year survey

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Anaphylactic reactions to muscle relaxants under general anesthesia

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Idiopathic anaphylaxis: total experience with 225 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Risk assessment in determining systemic reactivity to honeybee stings in sting-threatened individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Lack of reproducibility of a single negative sting challenge response in the assessment of anaphylactic risk in patients with suspected yellow jacket hypersensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Anaphylaxis. A review of 266 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Anaphylactic shock occurring outside hospitals.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Anaphylaxis in children: a 5-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Fatalities from immunotherapy (IT) and skin testing (ST)

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Immunological characterization and functional importance of human heart mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Histamine H3 receptor blockade improves cardiac function in canine anaphylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Extracellular deposition of eosinophil granule major basic protein in pressure urticaria

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Eosinophil cationic protein (ECP) level and its correlation with eosinophil number or IgE level of peripheral blood in patients with various skin diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Increased interleukin-6 production during the acute phase of the syndrome of episodic angioedema and hypereosinophilia.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

A case of episodic angioedema associated with blood eosinophilia: upregulated C5a receptor expression on eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Biochemical markers of anaphylactoid reactions to drugs. Comparison of plasma histamine and tryptase

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Preliminary report: complement activation in wasp-sting anaphylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Management of anaphylactic reactions to food

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Fatal and Near-Fatal Anaphylactic Reactions to Food in Children and Adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

The use of epinephrine in the treatment of anaphylaxis. AAAI Board of Directors

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

Treatment of acute anaphylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962318-6

7 January 2021

10.1016/S1081-1206(10)62318-6

Identifiers

DOI

1 reference

1 August 2017

1 reference